CEO, Pharmaceutical Segment
Mon, Nov 27, 2023
Nov 27
15,373 shares @ $66.43
Increased holdings by +27.20%
Net across this filing: -20.40% (-9,000 shares)
7th largest trade (out of 31)
Option ExerciseLarge Trade
Trade made by an officer
Sale tied to a same-time option exercise
Net holdings across this filing: -20.4% (-9,000 shares)
Insider trade was 38% below market price
Price 23% above 200-day moving average